Wegovy weight-loss drug reduced risk of serious heart problems by 20%, study finds
:max_bytes(150000):strip_icc()/GettyImages-16924367651-743d42c1c37645208d1f15521353917f.jpg)
15 across the spectrum · tap a section to jump
The story so far
2 developments- Nov 11, 2023Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds
- Nov 13, 2023Novo Nordisk's Wegovy reduces risk of serious heart problems by 20%, study shows
Who covered each development
No new developments
Quiet for 1051 daysLast development · Nov 13, 2023 — Novo Nordisk's Wegovy reduces risk of serious heart problems by 20%, study shows
Left
7 viewpointsWegovy Is Shown to Reduce Risk of Heart Attacks and Strokes in Some Patients
Center
4 viewpointsNovo Nordisk ADRs Climb After Study Suggests Its Wegovy Showed Heart Benefits
Wegovy weight-loss drug reduced risk of serious heart problems by 20%, study finds
Trial confirms heart benefits of Wegovy, but is weight loss responsible – or something else?
Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds
Right
4 viewpointsNovo Nordisk's Wegovy reduces risk of serious heart problems by 20%, study shows
Scientists have discovered a new benefit to Novo Nordisk’s weight-loss drug Wegovy: It can cut heart-related deaths by 20%, drugmaker reports
Wegovy's heart benefits due to more than weight loss, Novo says
Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds